Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer

NCT01757366 is registered in ClinicalTrials.gov with Hebei Tumor Hospital as lead sponsor.

NCT NCT01757366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01757366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer
Lead sponsor
Hebei Tumor Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2012
Completion date
December 31, 2016
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

self efficacy